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ABSTRACT
Bioinformatics and computer aided drug design rely on the curation of a large
number of protocols for biological assays that measure the ability of potential drugs
to achieve a therapeutic effect. These assay protocols are generally published by
scientists in the form of plain text, which needs to be more precisely annotated in
order to be useful to software methods. We have developed a pragmatic approach
to describing assays according to the semantic definitions of the BioAssay Ontology
(BAO) project, using a hybrid of machine learning based on natural language
processing, and a simplified user interface designed to help scientists curate their
data with minimum effort. We have carried out this work based on the premise
that pure machine learning is insufficiently accurate, and that expecting scientists
to find the time to annotate their protocols manually is unrealistic. By combining
these approaches, we have created an effective prototype for which annotation of
bioassaytextwithinthedomainofthetrainingsetcanbeaccomplishedveryquickly.
Well-trained annotations require single-click user approval, while annotations
from outside the training set domain can be identified using the search feature of
a well-designed user interface, and subsequently used to improve the underlying
models. By drastically reducing the time required for scientists to annotate their
assays, we can realistically advocate for semantic annotation to become a standard
part of the publication process. Once even a small proportion of the public body
of bioassay data is marked up, bioinformatics researchers can begin to construct
sophisticatedandusefulsearchingandanalysisalgorithmsthatwillprovideadiverse
andpowerfulsetoftoolsfordrugdiscoveryresearchers.
Subjects Bioinformatics, Computational Science
Keywords Bioassay, Ontology, Machine learning, Natural language processing, Bayesian,
Semantic curation
INTRODUCTION
In recent decades scientific data has been almost entirely digitized: authors prepare
their manuscripts and presentations using a collection of text, graphics and data
processing software. Consumers of scientific data regularly download documents from
publishers’ websites, search for content in databases, and share data with their colleagues
electronically, often in an entirely paperless fashion. Dozens of commercial and academic
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and user confirmation. PeerJ2:e524; DOI10.7717/peerj.524research groups are actively working on ways to use software to analyze this rapidly
expanding corpus of data to provide facile information retrieval, and to build decision
support systems to ensure that new research makes the best possible use of all available
priorart.
Despite the near complete migration from paper to computers (Khabsa & Giles, 2014),
the style in which scientists express their results has barely changed since the dawn of
scientific publishing. Whenever possible, ideas and facts are expressed as terse paragraphs
of English text, kept as short as possible to minimize printing costs, and as stripped down
diagrams that often summarize vast numbers of individual data points in a form that
can be visualized statically by a scientific peer. These methods of communication have
remained consistent because they are effective for their primary purpose, but this presents
amajorhurdletocomputersoftwarethatisattemptingtoperformdataminingoperations
onpublishedresults.
In the case of biological assays, experiments designed to measure the effects of
introduced substances for a model of a biological system or disease process, the protocols
are typically described in one or more textual paragraphs. Information about the target
biology, the proteins or cells, the measurement system, the preparation process, etc., are
all described using information rich jargon that allows other scientists to understand the
conditions and the purpose. This comprehension process is, however, expert-specific and
quite time consuming. While one scientist may read and understand dozens of published
assay descriptions, this is not scalable for large-scale analysis, e.g., clustering into groups
aftergeneratingpairwisemetrics,orsearchingdatabasesforrelatedassays.
One of the most promising approaches to solving this problem is to express the assay
design experiments with terminology from a semantically rich ontology, which has the
advantageofbeingreadilyunderstoodbysoftware(Jonquet,Musen&Shah,2010;Jonquet,
Shah & Musen, 2009; Roeder et al., 2010). Efforts such as the BioAssay Ontology (BAO)
project (Abeyruwan et al., 2014; Vempati et al., 2012; Visser et al., 2011) were specifically
designed to address this issue, and is part of a pantheon of ontologies for expressing the
chemistry and biology definitions and relationships that are essential to drug discovery.
Having all relevant scientific data expressed in semantic form enables an inordinate
number of options for building compelling decision support software, but the biggest
hurdle is the expression of the data. Expecting scientists to alter their documentation
habits to use computer-friendly ontologies rather than human-friendly natural language
is unrealistic, especially given that the benefits do not start to accrue until a critical mass
is achieved within the community. On the other hand, there has been a considerable
amount of research toward designing software to perform fully automated parsing of
otherwise intractable text and diagrams (Attwood et al., 2010), and add annotations in a
machine-friendly format. Many of these efforts have been found to be valuable for certain
scenarios where the high error rate is tolerable. For example, allowing a scientist to search
the entire patent literature for chemical reactions may be a very useful service even with a
low signal to noise ratio, because the effort required to manually filter out false positives
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methods(Hawizyetal.,2011;Jessop,Adams&Murray-Rust,2011;Jessopetal.,2011).
Nonetheless,suchfullyautomatedextractionproceduresarelikelytocontinuetohavea
veryhigherrorrateformostscientificsubjectareasfortheconceivablynearfuture,andthe
poor signal to noise ratio prevents most kinds of analysis from being effective. To address
this urgent issue, we have developed methods for combining automated extraction and
manual curation in order to optimize for both goals: minimal additional burden on prac-
ticingscientists,andminimaltranscriptionerrorsduringthesemanticmarkupprocess.
There are already examples of hybrid manual/automatic annotation technologies, for
example PubTator, (Wei, Kao & Lu, 2013) which is designed to help identify a variety of
keywords in order to classify papers within the PubMed collection. The web interface
providesaninitialattempttoidentifykeywordsthatcorrespondtosemanticcontentinthe
chemical or biological domain, and allows the user to confirm them or add their own. On
theotherhand,someofthelargescalecurationefforts,suchasChEMBL,providefunding
for expert curators to manually annotate bioassay data, but this is too labor intensive to
execute in detail, and is currently limited to identifying the target (Gaulton et al., 2012).
ApproachessuchasActiveLearning(AL)havealsobeenappliedtoclassificationofdomain
specific text documents (Cohn, Ghahraman & Jordan, 1996; Dara et al., 2014; Tomanek &
Hahn,2007).Ourobjectiveinthisworkistoprovidethenecessarycapabilitiestoannotate
bioassay protocols, in a significant level of detail, such that the semantic content is a rela-
tivelycompletedescriptionoftheassay.Inmanywaysouraimsaresimilartoothernatural
language text-based classification projects, but unusual in that we are ultimately seeking
to use these methods to express a very detailed description of a domain localized class
of experiments. We can draw upon existing vocabularies, such as the BioAssay Ontology
(BAO), and other ontologies, which it in turn references, for the means to complete this
description. To achieve the objective of reducing the burden on the individual scientist to
thebareminimum,wehavemadeuseofnaturallanguageprocessingandmachinelearning
techniques, and coupled the algorithms to a prototype user interface with a workflow
designthatiteratesbackandforthbetweenautomatedinferenceandoperatorapproval.
Rather than starting with the lofty objective of having an algorithm provide the right
answers all of the time, we merely require it to eliminate most of the wrong answers. To
the extent that we are able to achieve this comparatively realistic goal, this allows us to
create a user-facing service for which the scientist simply selects correct semantic markup
options from a short list of options proposed by the software. This is as opposed to the
entirelymanualcurationapproach,whichwouldrequiretheoperatortonavigatethrough
a densely packed hierarchy of descriptors. By reducing the burden of markup to mere
minutesbysomebodywhoisnotfamiliarwithsemantictechnology,andhashadnospecial
trainingforuseofthesoftware,itisquitereasonabletoexpectscientiststousethissoftware
aspartoftheirstandardwrite-upandsubmissionprocess.
As the number of correctly annotated bioassay protocols grows, it will improve the
trainingsetandthemachinelearningalgorithmwillcorrespondinglyimproveinaccuracy.
Once the currently high barrier to adoption has been overcome, and semantic markup
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will be as readable to computer software as they are to expert scientists. The informatics
capabilities that this will unlock are essentially limitless, but the first most clear example
is the ability to search assays for specific properties, e.g., target, assay type, cell line,
experimental conditions, etc. Being able to conveniently organize and aggregate assays
by particular characteristics, cluster by similarity, or assemble chemical structures and
activity from multiple assays based on customizable criteria, are all advantages that have
a direct impact on drug discovery, which are currently held back by the lack of semantic
annotation. Once the corpus of marked up annotations becomes large, it will also be
possible to construct data mining algorithms to study large scale trends in bioassay data,
whichwillresultinentirelynewkindsofinsightthatarecurrentlynotpossible.
METHODS
Ontologies
The primary annotation reference for this project is the BioAssay Ontology (BAO), which
is available from http://bioassayontology.org, and can be downloaded inraw RDF format.
The BAO classes refer to a number of other ontologies, and of particular relevance are the
Cell Line Ontology (CLO) (Sarntivijai et al., 2011), Gene Ontology (GO) (Balakrishnan
et al., 2013; Blake, 2013), and NCBI Taxonomy (Federhen, 2012), all of which are used for
annotations within the training set. All of the source files for these ontologies were loaded
intoaSPARQLserver(ApacheFuseki)(TheApacheSoftwareFoundation,2014a).SPARQL
queries were used to organize the available values that correspond to each of the property
groups.
Training data
In order to test the methodology of using text to create suggested annotations, we made
useofacorpusofannotatedbioassaysthatwereprovidedbytheBAOgroup(Schureretal.,
2011; Vempati et al., 2012) (see Supplemental Information). As part of the testing process
for the BioAssay Ontology project, a simple annotation user interface was created in the
form of an Excel spreadsheet template. Approximately 1,000 assays were selected from
PubChem, and each of these was painstakingly annotated, leading to an output document
takingtheformof:⟨assayID⟩⟨property⟩ ⟨value⟩.
Foreachassay,20–30annotationswereincorporatedintothetrainingset.Theproperty
values were individually mapped to the BAO space, e.g., ‘has assay method’ is mapped to
the URI http://www.bioassayontology.org/bao#BAO 0000212, which is a part of the BAO
ontology. Values that are string literals are not included in the training data. Those which
map to a distinct URI are typically part of the BioAssay Ontology directly, or part of other
ontologiesthatarereferenced,suchastheCellLineOntology(CLO),GeneOntology(GO)
andNCBITaxonomy.
Once the annotations had been suitably collated for each distinct assay, the NCBI
PubChem assays were obtained by a simple script making a call to the PUG RESTful API
(NCBI, 2014). In each case, the description and protocol sections of the resulting content
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scientists submitting new assay data varies considerably, but they are generally complete.
For the collection of text documents obtained, it was necessary to manually examine
each entry, and remove non-pertinent information, such as attribution, references and
introductory text. The residual text for each case was a description of the assay, including
information about the target objective, the experimental details, and the materials used.
Thevolumeoftextvariesfromconciselywordedsingleparagraphsummariestoverbosely
detailed page length accounts of experimental methodology. These reductively curated
trainingdocumentscanbefoundintheSupplementalInformation.
Natural language processing
There has been a considerable amount of effort in the fields of computer science and
linguistics to develop ways to classify written English documents in terms of classified
tokens that can be partially understood by computer software (Kang & Kayaalp, 2013;
Leaman,IslamajDogan&Lu,2013;Liu,Hogan&Crowley,2011;Santorini,1990).Wemade
use of the OpenNLP project (The Apache Software Foundation, 2014b), which provides
part of speech (POS) tagging capabilities, using the default dictionaries that have been
trained on general purpose English text. The POS tags represent each individual word as a
token that is further annotated by its type, e.g., the words “report” and “PubChem” were
classifiedasanordinarynounandapropernoun,respectively:
(NN report)
(NNP PubChem)
Blocksoftextareclassifiedinanincreasinglyspecifichierarchicalform,e.g.,
(NP (DT an) (JJ anti-cancer) (NN drug))
(VP (VBG developing) (NP (JJ potential) (JJ human) (NNS therapeutics)))
(NP (NP (NN incubation)) (PP (IN with) (NP (NN test) (NN compound))))
(NP (NP (DT the) (JJ metabolic) (NN activity)) (PP (IN of) (NP (DT a) (NN suspension)
(NN cell) (NN line))))
(VP (VB measure) (SBAR (WHADVP (WRB when)) (S (VP (VBG developing)
(NP (JJ potential) (JJ human) (NNS therapeutics))))))
(NP (JJ luciferase-based) (NN cell) (NN proliferation/viability) (NN assay) (NN endpoint))
An assay description of several paragraphs can generate many hundred distinct instances
ofPOS-taggedblocks.Thesemarkeduptokenscontainafarlargeramountofinformation
aboutthecompositionofthesentencethanthewordsthemselves.Whilebuildingamodel
bycorrelatingwordswithannotationswouldbeexpectedtoachievepoorresults,including
markup information about how the words are used in conjunction with each other might
be able to achieve far greater discrimination. For example, the POS-tagged block “(NP
(DT an) (JJ anti-cancer) (NN drug))” represents the words [an, anti, cancer, drug]. Each
of these 4 words taken out of context could be found in almost any assay description, but
whentheyareassociatedtogetherincontext,contributeanimportantstatementaboutthe
correspondingbiochemistry.
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many different depths of linguistic structure the opportunity to distinguish themselves
within a model. In some cases a single word can have significant meaning on its own,
especially proper nouns or jargon (e.g., “luciferase”), and are likely to have a high
correlation to certain kinds of annotations (e.g., use of a luciferase-based assay). Other
words are general to the English language, or occur frequently in assay descriptions, such
thattheyonlyhavevalueintheirpropercontext(e.g.,“interaction”).
One of the useful properties of scientific writing is that authors have self-organized
around a narrow range of styles for presenting information such as assay descriptions.
While the explicit intent may not have been for the benefit of computerized natural
language processing, the motivation is the same: scientific authors also read many other
published descriptions, and it is in the best interests of the community to maintain a
certain degree of consistency as well as brevity. Because the literary style lacks prose
and has a relatively little variation, there are certain blocks of words, as identified by
the POS-tagging, that are frequently correlated with particular concepts, and hence the
semanticannotations.
Machine learning models
A collection of hundreds of assay descriptions will result in thousands of distinct
POS-taggedblocksafterprocessingeachofthemwithnaturallanguageanalysis,andwhile
certain blocks are likely to be specifically correlated with certain annotations, there are
many more with only weak correlation or none at all. Matching thousands of potentially
important tags with hundreds or thousands of annotations requires the selection of an
algorithm with favorable scaling properties, and is well beyond the scope of manual
curation.
In our initial explorations, we chose to apply a variation of Bayesian inference, which
has been used successfully in other aspects of computer aided drug discovery. The
Laplacian-modifiedna¨ ıveBayesianvariantisfrequentlyusedinconjunctionwithchemical
structurebasedfingerprints(Hassanetal.,2006;Mussa,Mitchell&Glen,2013;Nidhietal.,
2006;Rogers,Brown&Hahn,2005),asitishighlytolerantoflargenumbersofparameters.
Thescoreforeachannotationiscalculatedas:
score =

n
ln

An +1
Tn ·P+1

where n is the tagged natural language block, An is the number of documents containing
the annotation and the tagged block, Tn is the total number of documents with the
tagged block, and P is the fraction of documents containing the annotation. The score
is computed by adding up the logarithms of these ratios, which circumvents issues with
numericprecision,butproducesascorewitharbitraryscale,ratherthanaprobability.
When we considered each individual annotation as a separate observation, building
a Bayesian model using the presence or absence of each distinct POS-tagged block
gave rise to a highly favorable response for most annotations, as determined by the
receiver–operator-characteristic (ROC) curves. Selected examples of these models are
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processing.
shown in Fig. 1: Fig. 1A shows annotations with high training set coverage that perform
well, due in part to having relatively unambiguous word associations, while Fig. 1B shows
well covered annotations that perform poorly, due to being reliant on terms that can be
used in a variety of contexts that do not necessarily imply the presence of the annotation,
and hence make it more difficult for the model to eliminate false positives. Similarly,
Fig.1Cshowstheperfectrecallforlesswellcoveredannotations,whichareeasilyidentified
due to very specific terms, while Fig. 1D shows a relatively poor response due to small
trainingsetandterminologywithvariationsinwordingstyle.
One of the disadvantages of using this Laplacian corrected variant is that the computed
valueisnotaprobability,butratherascorewitharbitraryrangeandscale.Thismeansthat
it is not possible to compare the outcomes from two separate models, which is a problem,
since the objective of this technology is to rank the scores that are obtained from each
separatemodel.Inordertoachievetheranking,thescoresneedtobedirectlycomparable,
and hence be suitable for providing a list of suggestions for which annotations are most
likelytobeassociatedwiththetext.
In order to make the scores from each of the models comparable, each model requires
a calibration function. This can be accomplished effectively by defining a simple linear
correction for each model, of the form y = ax+b, which is applied to each score prior to
inter-model comparison. Selecting appropriate values for a and b, for each model, can be
achievedbypickinginitialvaluesthatmapeachofthemodeloutcomestotherange0.1.By
adjusting the scale and offset of the linear calibration functions for each of these models,
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 7/23theoverallabilityofthemodelstocorrectlyranktheextantannotationswithahigherscore
thanthosewhicharenotobservedcanbeevaluated.Itisstraightforwardtodefineascoring
term that measures the ability of the calibrated models to distinguish between correct and
incorrect annotations. This score can be optimized by iteratively adjusting the calibration
termstogetthebestoverallseparationinranking.
Besides consistent use of linguistic descriptions of assays, one of the other observations
about the annotations defined for these assay protocols is that they are not in any way
orthogonal: the degree to which the annotations are correlated is very high. For example,
if it is known that the assay uses luciferin as a substrate, the probability that it also involves
luminescence as a detection method is far higher than it would be if the prior fact had not
alreadybeenestablished.
Given that the calibrated Bayesian models have been established to perform very well
at placing the top few highest ranking annotations for the data used in this study, once
thesetopscoringannotationshavebeenconfirmedbytheuser,theamountofinformation
that can be inferred about the assay may be significantly greater, due to the high degree of
correlation.
This second order correlation was implemented by building another set of Bayesian
models with each possible annotation considered separately as an observation. For
each document, each annotation’s likely presence is modeled against the presence or
absence of all the other annotations recorded for the document, e.g., when building the
correlation model for annotation A, if document i contains annotations A, B and C, then
itisconsideredtobe“active”,withpriorsBandC;ifdocumentj containsannotationsB,C
andD,itisconsidered“inactive”,withpriorsB,C andD.
Thus, once one or more annotations have been assigned, the secondary Bayesian
models are consulted, and the score for each of the annotations is modified by applying
the correlation factor. Essentially this means that as the user approves annotations, the
prediction scores of the remaining annotations tends to improve, as the correlations are
factoredin.
Figure 2 provides an indication of how the ranking evolves during the model building
steps, using four example documents. For each of these diagrams, the left hand side shows
two bands which represent the uncalibrated predictions, which are linearly normalized
so their values fall between the minimum and maximum scores from the raw Bayesian
prediction score. The annotations that do not apply to the document are shown as red
lines, while the annotations that are present are shown in black. The height of each line is
indicative of its score. As can be clearly seen, the desired predictions score are significantly
higher for those present than those which are absent, but the extent to which the ranking
separates the two groups varies, and is not initially a perfect separation for any of these
examples.
The main area of each diagram shows the progression of the relative predictions: at the
beginning of the sequence, the scores are ranked by the inter-model calibration functions,
which typically results in a significant improvement. For each of the subsequent steps, the
highest scoring correct annotation is added to the approved set, and the correlation model
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brated, calibrated, and stepwise application of the correlation models. The four examples refer Pub-
Chem entries by assay ID: (A) 574, (B) 436, (C) 348 and (D) 346.
is updated and applied. The ranking is redetermined, and the next highest scoring correct
annotationisselected.Thediagramindicatesthepointatwhicheachannotationisselected
by plotting a black circle, and changing the color of the line to green: since it has been
confirmed,itsrankingorderisnolongeraconcern,thoughitspresencecontinuestoaffect
thewaythecorrelationmodelisapplied.
Inthefirstexample,showninFig.2A,applicationofthesemodelsinthegivensequence
provides a perfect result: in each case the highest scoring annotation yet to be selected is
at the top of the list, with no false positives. In Figs. 2B and 2C, the results are good but
not perfect: the red cross marks indicate when an incorrect annotation was presented
as the best next choice. Since this exercise is simulating curation by a human expert,
the elimination of a top-ranked incorrect proposal is equivalent to being recognized by
the user as an incorrect result, and explicitly excluded from further consideration. If the
objective was to provide a pure machine learning solution, each of these ranking mistakes
would represent the accumulation of bad data, rather than a small increase in the amount
of effort required by the operator. In Fig. 2D, the response of the model is relatively poor,
with several false positives appearing close to the top of the list, and the last few correct
resultsbeingobscuredbyalargenumberofincorrectlyrankedproposals.
RESULTS
We have designed the algorithm with the goal of ranking the available annotations such
that given a text description of an assay, the annotations that correctly apply to the
document are listed before any which do not. A perfect result is considered to be any
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 9/23Figure 3 Effectiveness of ranking of activities. (A) hit/miss for test data; (B) heatmap for model size;
(C) null hypothesis; (D) hit/miss for training data.
casewhereallofthecorrectproposalsarerankedfirst.Becausetheobjectiveofthemachine
learning is to assist and accelerate the human-guided curation, a handful of mis-ordered
annotations can be considered as an inconvenience, rather than the means by which data
becomescorrupted.
For evaluation purposes, we define a yardstick measure: the null hypothesis is that the
Bayesian-trainedmodelusingnaturallanguageprocessingperformsnobetterthanatrivial
method,suchasrankingallproposedannotationsbythefrequencywithwhichtheyoccur
inthetrainingset.
Cross validation
The 983 fully annotated assays, with corresponding text from PubChem, were split into
training and test sets using a simple partitioning algorithm. First of all, 208 documents
wereremovedonaccountofhavingthesamelistofproperty:valueannotations.Thesedoc-
uments may differ by the free text annotations, but these are not included in the training
set, and so duplicates need to be pruned. Of the remaining documents, entries were selec-
tivelypickedforthetestsetinordertoensurethateachannotationappearsonceinanyone
of the test set documents, but such that the number of instances remaining in the training
setwasnotreducedbelow2.Thetrainingsetcontained698documents,thetestset77.
The models were rebuilt using just the training set documents, and applied to the test
set.Forevaluationpurposes,wecanconsidertherankingofcorrectvs.incorrectanswersto
be instructive for how well the model achieves its stated goal. Figure 3 shows several plots
thatshowtherelativeperformanceofthetrainingandtestsets.
Thedataforeachplotiscreatedaccordingtothefollowingprocedure:
1. scoreeachavailableannotationbasedonthemodelderivedfromthetrainingsetdata;
2. pick the highest scoring annotation: if it is correct, add a positive mark, remove the
annotation,andgoto1;
3. itisnotcorrect,soaddanegativemark,removetheannotation,andgoto2.
This essentially simulates an expert operator who only looks at the current top scoring
annotation, and either approves it, or excludes it from further consideration. The process
stopswhenallcorrectannotationshavebeenapproved.
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the test set documents are considered: for each line, running from left to right, a correct
top ranking annotation is marked with a black square, while an incorrect top ranking
annotation is marked with a purple square. Once all of the correct annotations have been
picked, the remaining space is marked in grey. As can be seen, for the majority of cases
the correct annotations are quickly picked out. Nonetheless there are a number of test
documents that contain a small number of outliers, i.e., required annotations that are
rankedverypoorly,withmanyfalsepositivesgettingahigherscore.
Figure3Bshowsthesamedatapoints,exceptthatonlytheactualannotationsaregivena
color. The color is determined by a heatmap pattern, for which green indicates predictions
that were derived from a well-populated model with many examples, while red indicates
thoseforwhichverylittletrainingdatawasavailable.Ascanbeseen,theoutliersthatrank
very poorly relative to the false positives are all colored red, which strongly suggests that
poorperformanceisduetosparsityoftrainingdata,ratherthanflawswiththemethod.
In Fig. 3C, the method for scoring documents is set to the frequency of each annotation
in the overall training set, e.g., if an annotation occurs 100 times in 698 documents,
its score is set to 0.143. The same proposed ranking order is used for all documents,
regardless of the text description. This is used to test a reasonable null hypothesis, which
is that picking the most common annotations is an effective way to separate correct from
incorrect. While it can be clearly seen that the null hypothesis performs better than a
random guess, at least for purposes of identifying true positives, it is vastly inferior to the
proposals generated by the trained Bayesian-derived models, on account of the fact that
everydocumenthasaverylargenumberoffalsepositivesthatneedtobeeliminatedbefore
theannotationiscomplete.
Figure 3D shows the same process as for Fig. 3A, except that in this case the training
dataisused,i.e.,themodelsareusedtopredictthesamedocumentsfromwhichtheywere
trained. These results are superior to applying the models to the test set, which is to be
expected.
Operator workflow
The ultimate goal of combining machine learning with a user interface for bioassay
annotation is to have the models predict all the correct annotations with close to perfect
accuracy, and have the expert operator confirm these predictions. In practice this is
realistic only when the document being annotated consists of cases that are well covered
in the training set. Due to the nature of science, there will always be new methods being
developed,whichmeansthatsomeofthecorrespondingannotationsmayhaveinsufficient
examples to create a model. It is also possible that the choice of phrasing for some of the
assaydetailsdifferssignificantlyfromthelanguageusedbytheexamplesinthetrainingset,
whichcanreducetheefficacyofthemodels,untiladditionaldatacanbeincorporatedand
usedtore-trainthem.
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predictions are correct, and (2) when the document is unable to accurately predict the
annotations. For the first scenario, confirming the correct annotations should be a matter
ofquicklyscanningthehighestscoringproposalsandconfirmingtheassignments.Inthese
cases,theuserinterfacemustaspiretobeingunobtrusive.However,inthesecondscenario,
when the correct annotation does not appear at the top of the list, the interface needs to
provide ways for the user to hunt down the necessary annotations. We have conceived
several options to help the user deal with this case. In near-ideal cases, the user may
find the correct annotation by simply looking slightly further down the list of proposed
annotations. Alternatively, the user may filter the results by selecting a particular category
of annotations, and browse through this refined subset to find the correct annotation.
Finally, if the user needs to include an annotation that is present in the ontology, but
has not been included in the list of proposals because there is not enough data to build
a model, the interface can provide assistance in searching through all of the unscored
options. Furthermore, there will also be occasions when the desired annotation does not
existintheontology,e.g.,apreviouslyunreportedbiologicalpathway,inwhichcaseitmay
be desirable to allow the user to enter the information as plain text. While this has little
immediate value for semantic purposes, it could be considered as a placeholder for future
additionstotheunderlyingontology,whichcouldbeupgradedretroactively.
A mockup of the core elements of this interface is shown in Fig. 4, which shows the
same layout principles for the proof of concept application that we created for testing the
machine learning methods and corresponding workflow. The box shown at the top left
allowstheusertotypeinfreetext.Thiscouldbecut-and-pastedfromanotherapplication,
oritcouldbetypedinmanually.Thelistimmediatelybelowshowsaseriesofannotations,
consistingofproperty andvalue.Thesearerankedhighestfirst.Whenthesystemisworking
perfectly, the user can click on the approve button for the highest scoring annotation,
shown at the top of the list. If the highest scoring annotation is not correct, the user
may look further down the list in order to find one that is correct; or, they may reject an
incorrectproposal.Ineithercase,theproposalsarerecomputed,andanewlistofoptionsis
shown.
On the right hand side of the screen is shown all of the available properties, which are
usedtoorganizetheannotations:foreachpropertyorcategory,therecanbezero-or-more
assigned annotations, of the property:value form. This simple hierarchical arrangement
clearly shows the annotations that have been assigned so far, and which properties have
as yet no associations. Making the property icons clickable is a way to allow filtering of
the annotation list, i.e., only showing the potential annotations that match the selected
property. In this way, the operator can carefully pick out assignments for each of the
property groups, which is a workflow that becomes important when working with
documents that do not fall within the domain of pretrained data. This process of picking
out the correct assignment can either be done by scrolling through the list of all possible
annotationsrankedaccordingtothepredictivescore,orbypartialtextsearching.
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 12/23Figure 4 A mockup of an interactive graphical user interface for annotating bioassays, with guidance
frompretrainedmodels.
Domain example
Figure 5 shows the annotation of an assay, which can be found in PubChem (Assay ID
761). The annotation text has been composed by concatenating the assay description
and protocol text fields, and trimmed to remove superfluous content, which is shown in
Fig. 5A. This case is an example where the performance of the machine learning models
is strong, but still requires a well-designed user interface for the portions that are less well
covered.
Steps(B)through(Y)showeachoftheassignmentsteps:inmostoftheseexamples,the
5highestrankedannotationsareshown.Inmostoftheinitialsteps,thetoprankedcaseisa
correctlypredictedannotation.Agreencheckboxisusedtoindicatethattheuserconfirms
that presence of the annotation, and in the following step, the list of proposals is updated
to reflect the modified scores, which take into account the correlation effects. In cases (L),
(Q), (R) and (T), the top ranked prediction is incorrect, and a red cross mark indicates
thattheuserexplicitlyexcludestheannotationfromfurtherconsideration.Instep(W)the
desiredannotationisfurtherdownthelist,andsotheuserscrollstheproposalsinorderto
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 13/23Figure 5 Stepwise annotation process for PubChem Assay ID 761, http://pubchem.ncbi.nlm.nih.gov/rest/pug/assay/aid/761/description/
JSON.
select the next correct one. In step (X), the user needs to add the annotation bioassay type:
binding assay,whichhasnotbeenrankedwellintheoverallscheme,andsothelistofanno-
tations isfiltered by selecting thebioassay type property, toonly show these corresponding
values. In step (Y) the user is looking to find the GPCR signal pathway annotation, which
is not a part of the training set, due to insufficient data to build a model. In order to locate
thisannotation,theuserentersasearchstringtonarrowdownthelistandlocateit.
In Fig. 5Z, the complete list of annotations, divided into property categories, is shown.
This list is updated dynamically as each of the annotations is added to the collection. The
properties for cell line, assay kit and inducer have no corresponding annotations, since
thesearenotapartoftheassay.
Semantic output
The purpose of adding semantic annotations to bioassays is to enable a diverse range of
queriesandautomatedanalysis,andoneofthemosteffectivewaystoenablethisisloadthe
annotationmarkupintothesameframeworkastheoriginalBioAssayOntologydefinition
andallofitsrelateddependencies.
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 14/23The output from an annotated description can easily be expressed in terms of RDF
triples. The properties and values are already mapped into the BAO space. A new URI
needs to be defined for each of the assays being annotated. For example, the annotation
exampleusedearlier,convertedintoRDF“Turtle”format,isshowninFig.6.
Onceinthisformat,theassertionscanbeloadedintoanexistingSPARQLserver.Atthis
pointthecontentbecomesaccessibletothefullsuiteofsemantictechnologies.Combining
thegenericqueryingcapabilitiesoftheSPARQLsyntax,withthesemanticstructureofthe
BioAssayontology,allowsavarietyofadhocquestionstobeanswered.
Forexample,findingalistofannotateddocumentsthatmakeuseofaspecificassaykit:
PREFIX rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#>
PREFIX owl: <http://www.w3.org/2002/07/owl#>
PREFIX xsd: <http://www.w3.org/2001/XMLSchema#>
PREFIX rdfs: <http://www.w3.org/2000/01/rdf-schema#>
PREFIX bao: <http://www.bioassayontology.org/bao#>
PREFIX cdd: <http://www.collaborativedrug.com/bao/curation.owl#>
SELECT ?aid WHERE
{
?assaykit rdfs:label "HTRF cAMP Detection Kit" .
?has rdfs:label "has assay kit" .
?document ?has ?assaykit .
?document cdd:PubChemAID ?aid
}
This simple query extracts a list of assay identifiers for anything that makes use of a
specific manufacturer’s cyclic AMP detector. Note that the property and value URIs are
matched by cross referencing the label. Based on the training data, this query returns AID
numbers933,940,1080,1402,1403,1421,1422and488980.
A slightly more advanced query can extract information other than just document
identifiers:
SELECT ?instrument ?aid WHERE
{
?document bao:BAO_0002855 bao:BAO_0000110 .
?document bao:BAO_0000196 bao:BAO_0000091 .
?document bao:BAO_0000207 bao:BAO_0000363 .
?document bao:BAO_0002865 ?q .
?q rdfs:label ?instrument .
?document cdd:PubChemAID ?aid
}
ORDER BY ?instrument ?aid
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 15/23Figure6 RDFTriplesfortheannotationofPubChemassayID761.
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 16/23In this case the restrictions are specified by directly referencing the BAO tags, which
searches for all protein-small molecule interaction assays, with inhibition as the mode
of action, using fluorescence intensity measurements. For each match, the detection
instrumentislookedupandcrossreferencedbylabel:
EnVision Multilabel Reader 622
PHERAstar Plus 1,986
ViewLux ultraHTS Microplate Imager 2,323
ViewLux ultraHTS Microplate Imager 485,281
ViewLux ultraHTS Microplate Imager 489,008
The inheritance hierarchy of the BioAssay Ontology, and the ontologies it references,
can also be utilized in queries. The following query looks for assays that target GPCRs of
mammals:
SELECT ?organism ?aid WHERE
{
?mammal rdfs:label "mammalian" .
?target rdfs:subClassOf* ?mammal .
?target rdfs:label ?organism .
?document bao:BAO_0002921 ?target .
?q rdfs:label "G protein coupled receptor" .
?document bao:BAO_0000211 ?q .
?document cdd:PubChemAID ?aid
}
ORDER BY ?organism ?aid
The target variable is used to match any organism URI that is a subclass of mammals.
Theresultisanumberofassaysforhumans,ratsandmice.
Each of these examples shows how the semantic markup of the annotated assays can
be put to the test with very direct and specific adhoc questions. These queries can be
composed on the fly by software that provides a more intuitive user interface, or they can
be used for developing new kinds of analyses by experts. They can be applied to just the
bioassay data in isolation, or they can be spliced into the greater semantic web as a whole,
and linked to all manner of other information resources, e.g., screening runs measuring
drug candidates, or medical knowledgebases that go into more detail about the biological
systemsbeingassayed.
Future work
The hybrid interactive/machine learning approach to bioassay annotation is currently a
proof of concept product. The prototype user interface is presently being evaluated by
scientists with an interest in improving software annotation of biological data, and we are
actively assessing the results in order to improve the workflow. The long-term goal is to
providetheuserinterfaceintheformofawebapplication,whichwillbeincorporatedinto
larger products that provide data capture functionality, such as the CDD Vault developed
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 17/23by Collaborative Drug Discovery Inc. or potentially public databases such as PubChem.
Thesemanticannotationswillberecordedalongsidethetextdescription,andimmediately
accessible,sharable,searchableandusedbyavarietyoffeaturesthatcanprovidereasoning
capabilitiesbasedonthisdata.
One of the obvious advantages of having user-approved annotations stored in a
centralized location is that the machine learning models can be retrained at periodic
intervals,whichwillensurethattheeasewithwhichuserscanrapidlyannotatetheirassays
continues to improve as more data is submitted. Also, as more data becomes available, the
domain of the models will continue to grow: annotations that were previously left out of
the model building process due to insufficient case studies will be added once they have
beenused.
Another potential advantage of centralization is to provide a pathway for new semantic
annotations, i.e., when the BioAssay Ontology and its dependencies do not provide an
appropriate term, users can resort to using a free text placeholder. Such annotations can
be examined on a regular basis, and either a manual or automated process can be devised
to collect together repeated use of related terms, and define a new annotation (e.g., for
a new class of biological target or a new measurement technique). This requires a single
authority to decide on a universal resource identifier (URI) for the new term, which could
be done by the service provider hosting the data, who may also take the opportunity to
retroactively upgrade the existing examples of free text labels to use the freshly minted
semantic annotation. We have also demonstrated creating a file containing RDF triples
for the resulting annotations for a document, and are looking into harmonizing the data
formatwiththeAssayDefinitionStandardformat(ADS/ADF)(deSouzaetal.,2014;Lahr,
2014).
In addition to working with potential users of this software, we are also looking to
incorporatemorepubliccontent,fromlargecollectionservicessuchasPubChem(Wanget
al.,2014;Zhangetal.,2011),BARD(deSouzaetal.,2014),ChEMBL(Bellisetal.,2011)and
OpenPHACTS (Williams et al., 2012). There are a number of research groups exploring
ways to add semantic markup to drug discovery data, including bioassays, and many of
these annotations can be mapped to the BAO annotations that we have chosen for this
project.Eventhoughwehavefoundinourinternalevaluationeffortsthatannotationtime
can be plausibly reduced to a matter of minutes, this is still a significant burden to impose
onbusyscientists,especiallyifparticipationisvoluntary.Asweconsiderdeploymentofthe
service, it is important to ensure that the benefits of assay annotation are realized as early
as possible, rather than waiting for critical mass, which might otherwise not be achieved.
Allowing scientists to use their annotated assays to easily search for similar assays within
a database, or as a convenient way to label and categorize their own collections of assays,
are anticipated to be effective strategies to make the technology useful during the early
adoptionphase.
Thinking broadly, one interesting possible use case for the annotation scheme is to
run it in reverse: to have the software use the annotations to assemble a paragraph of
plain English text, which is suitable for incorporation into a manuscript. In this case
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 18/23the workflow would likely be quite different, e.g., the user types in a poorly formatted
collectionoftermsinvolvedintheassayinordertohelptheinferenceenginerankthelikely
suggestions, selects the appropriate terms, and then has the text produced by the software.
Suchaservicecouldbeofsignificantusetoscientistswhoarenotexperiencedwithwriting
assayproceduresaccordingtothestandardstyleguides.
As part of our ongoing work, we are evaluating our selection of annotations from the
underlying ontology. Our initial prototype is strongly influenced by the training data that
we have available, which is the result of hundreds of hours of work by qualified domain
experts. We are actively working with biologists and medicinal chemists to determine
which properties are of primary importance, and which are secondary, and to expand our
collectionoftrainingdatatoreflecttheprioritiesofactivedrugdiscoveryresearchers.
Beyond the use of bioassays and BAO annotations for training data, the methodology
developedisbroadlyapplicableandnotspecifictothisdomain.Weanticipatethatthereare
a number of other distinct subject areas of scientific publications that would be amenable
tothistreatment,e.g.,experimentaldetailsofchemicalreactions,computationalchemistry
protocols, and other types of biological protocols beyond drug discovery, such as stem cell
differentiation.
CONCLUSION
We have built a proof of concept framework that involves using machine learning based
on plain text assay descriptions and curated semantic markup, and matched this with a
user interface that is optimized for making machine-assisted annotation very rapid and
convenient when applied to text input that is well within the domain, and moderately
efficient for annotating assays that fall outside of the training set. By optimizing both
the machine learning and user-centric workflow at the same time, we avoid falling into
the traps of both extremes, because both parts complement each other. Annotation
of plain text by purely automated methods has been limited by the need to obtain an
unrealistic level of accuracy, while purely manual annotation has to overcome a very high
motivationalbarrier, giventhatmost scientistsaretoo busytotake onadditionalburdens,
withoutanimmediatebenefit.Byestablishingthataddingaverymodestamountofhuman
effort to a well designed automated parser can achieve highly accurate results, we believe
that we can make a strong case for the use of this technology in the hands of practicing
scientists.
As the quantity of semantically rich annotated data increases, the opportunities for
delivering value to scientists increases in tandem. Making annotation easy is the first
step, but it needs to be followed by new capabilities. For example, the creators of assay
screens should be able to easily compare their experiments with others contained within
the knowledgebase, and obtain a list of experiments and published papers with common
features. Researchers performing drug discovery modeling studies should be able to
gather together compounds that have been screened under certain conditions, and use
the annotations to make a judgment call as to whether the measured activities can be
incorporated into the same model. Additionally, researchers can search for artifacts, such
Clark et al. (2014), PeerJ, DOI 10.7717/peerj.524 19/23as compounds that are disproportionately active in luminescent assays. New biological
activities may alsobecome mineable; for example, common hits between cell-based assays
andtargetbasedassaysmayrevealunknownmolecularmechanisms.
Beyondthespecificdomainofbioassayannotation,webelievethatthehybridapproach
to high level markup is appropriate to many different areas of science, where use of
English text jargon or anachronistic diagrams is the norm for conveying concepts that are
amenable to a highly structured description. The understandable reluctance of scientists
to redesign their communication methods for the benefits of software, and the inability
of software to provide substantially useful results without such richly marked up data,
is a proverbial chicken vs. egg scenario that can be observed throughout the scientific
disciplines. Combining machine learning with modest demands on scientists’ time, and
rapid iteration of improved functionality, is a viable strategy for advancing the goals of
computerassisteddecisionsupport.
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